• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种用于前列腺癌预后的新型六个自噬相关基因特征以及一种用于抗PD-1治疗反应的miRNA相关自噬预测指标。

Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.

作者信息

Wu Lei, Quan Wen, Yue Guojun, Luo Qiong, Peng Dongxu, Pan Ying, Zhang Guihai

机构信息

Department of Oncology, Zhuhai People's Hospital (Zhuhai Hospital affiliated with Jinan University), Zhuhai, Guangdong Province, P. R. China.

Zunyi Medical University, Zunyi, Guizhou Province, P. R. China.

出版信息

BMC Cancer. 2021 Jan 5;21(1):15. doi: 10.1186/s12885-020-07725-0.

DOI:10.1186/s12885-020-07725-0
PMID:33402116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7786978/
Abstract

BACKGROUND

Autophagy is a highly conserved homeostatic process in the human body that is responsible for the elimination of aggregated proteins and damaged organelles. Several autophagy-related genes (ARGs) contribute to the process of tumorigenesis and metastasis of prostate cancer (PCa). Also, miRNAs have been proven to modulate autophagy by targeting some ARGs. However, their potential role in PCa still remains unclear.

METHODS

An univariate Cox proportional regression model was used to identify 17 ARGs associated with the overall survival (OS) of PCa. Then, a multivariate Cox proportional regression model was used to construct a 6 autophagy-related prognostic genes signature. Patients were divided into low-risk group and high-risk group using the median risk score as a cutoff value. High-risk patients had shorter OS than low-risk patients. Furthermore, the signature was validated by ROC curves. Regarding mRNA and miRNA, 12 differentially expressed miRNAs (DEMs) and 1073 differentially expressed genes (DEGs) were detected via the GEO database. We found that miR-205, one of the DEMs, was negatively regulated the expression of ARG (NKX2-3). Based on STRING analysis results, we found that the NKX2-3 was moderately related to the part of genes among the 6 autophagy-related genes prognostic signature. Further, NKX 2-3 was significantly correlated with OS and some clinical parameters of PCa by cBioProtal. By gene set enrichment analysis (GSEA). Lastly, we demonstrated that the association between NKX2-3 and tumor mutation burden (TMB) and PDCD1 (programmed cell death 1) of PCa.

RESULTS

We identified that the six ARGs expression patterns are independent predictors of OS in PCa patients. Furthermore, our results suggest that ARGs and miRNAs are inter-related. MiR-205 was negatively regulated the expression of ARG (NKX2-3). Further analysis demonstrated that NKX2-3 may be a potential biomarker for predicting the efficacy of anti-PD-1 therapy in PCa.

CONCLUSIONS

The current study may offer a novel autophagy-related prognostic signature and may identify a promising miRNA-ARG pathway for predicting the efficacy of anti-PD-1 therapy in PCa.

摘要

背景

自噬是人体中一种高度保守的稳态过程,负责清除聚集的蛋白质和受损的细胞器。几种自噬相关基因(ARGs)参与前列腺癌(PCa)的肿瘤发生和转移过程。此外,已有研究证明miRNA可通过靶向某些ARGs来调节自噬。然而,它们在PCa中的潜在作用仍不清楚。

方法

使用单变量Cox比例回归模型来识别与PCa总生存期(OS)相关的17个ARGs。然后,使用多变量Cox比例回归模型构建一个6个自噬相关预后基因特征。以中位风险评分作为临界值,将患者分为低风险组和高风险组。高风险患者的OS比低风险患者短。此外,通过ROC曲线对该特征进行验证。关于mRNA和miRNA,通过GEO数据库检测到12个差异表达的miRNA(DEMs)和1073个差异表达基因(DEGs)。我们发现,DEM之一的miR-205对ARG(NKX2-3)的表达具有负调控作用。基于STRING分析结果,我们发现NKX2-3与6个自噬相关基因预后特征中的部分基因中度相关。此外,通过cBioProtal分析发现NKX 2-3与PCa的OS和一些临床参数显著相关。通过基因集富集分析(GSEA)。最后,我们证明了NKX2-3与PCa的肿瘤突变负荷(TMB)和程序性细胞死亡蛋白1(PDCD1)之间的关联。

结果

我们确定这六个ARGs的表达模式是PCa患者OS的独立预测因子。此外,我们的结果表明ARGs和miRNA相互关联。MiR-205对ARG(NKX2-3)的表达具有负调控作用。进一步分析表明,NKX2-3可能是预测PCa抗PD-1治疗疗效的潜在生物标志物。

结论

本研究可能提供一种新的自噬相关预后特征,并可能确定一条有前景的miRNA-ARG途径,用于预测PCa抗PD-1治疗的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f59eaaf09624/12885_2020_7725_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/d0b3bf8d50dc/12885_2020_7725_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f50cc3536225/12885_2020_7725_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/71d57334b8ca/12885_2020_7725_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f8ffbe293964/12885_2020_7725_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/9d844317adc5/12885_2020_7725_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/1c6dc2832285/12885_2020_7725_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/700eb2e52290/12885_2020_7725_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/4c10da68cab4/12885_2020_7725_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/8e4a0dc25d06/12885_2020_7725_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f59eaaf09624/12885_2020_7725_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/d0b3bf8d50dc/12885_2020_7725_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f50cc3536225/12885_2020_7725_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/71d57334b8ca/12885_2020_7725_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f8ffbe293964/12885_2020_7725_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/9d844317adc5/12885_2020_7725_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/1c6dc2832285/12885_2020_7725_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/700eb2e52290/12885_2020_7725_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/4c10da68cab4/12885_2020_7725_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/8e4a0dc25d06/12885_2020_7725_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff4/7786978/f59eaaf09624/12885_2020_7725_Fig10_HTML.jpg

相似文献

1
Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.鉴定一种用于前列腺癌预后的新型六个自噬相关基因特征以及一种用于抗PD-1治疗反应的miRNA相关自噬预测指标。
BMC Cancer. 2021 Jan 5;21(1):15. doi: 10.1186/s12885-020-07725-0.
2
Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.自噬相关长链非编码 RNA 在前列腺癌中的表达状态及预后价值。
Cell Cycle. 2022 Aug;21(16):1684-1696. doi: 10.1080/15384101.2022.2065149. Epub 2022 Apr 24.
3
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.建立一个自噬相关基因表达谱,用于预测前列腺癌患者的预后。
J Transl Med. 2020 Apr 7;18(1):160. doi: 10.1186/s12967-020-02323-x.
4
Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.通过综合生物信息学分析鉴定高级别前列腺癌的潜在 miRNA 生物标志物。
Pathol Oncol Res. 2019 Oct;25(4):1445-1456. doi: 10.1007/s12253-018-0508-3. Epub 2018 Oct 26.
5
Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.用于前列腺癌转移的生物标志物 microRNAs:通过网络脆弱性分析模型筛选。
J Transl Med. 2018 May 21;16(1):134. doi: 10.1186/s12967-018-1506-7.
6
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.鉴定小分子药物并开发用于肾透明细胞癌的新型自噬相关预后标志物。
Cancer Med. 2020 Oct;9(19):7034-7051. doi: 10.1002/cam4.3367. Epub 2020 Aug 11.
7
Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer.自噬相关环状 RNA 评估显示 hsa_circ_0001747 可作为前列腺癌患者生化复发的潜在有利预后因素。
Cell Death Dis. 2021 Jul 22;12(8):726. doi: 10.1038/s41419-021-04015-w.
8
Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.建立和验证一个用于乳腺癌患者的新型自噬相关基因特征。
Gene. 2020 Dec 15;762:144974. doi: 10.1016/j.gene.2020.144974. Epub 2020 Jul 22.
9
A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.一个四 miRNA 特征作为预测子宫内膜癌患者生存的新型生物标志物。
Gene. 2019 May 20;697:86-93. doi: 10.1016/j.gene.2019.01.046. Epub 2019 Feb 16.
10
Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.构建和分析 mRNA、miRNA、lncRNA 和 TF 调控网络揭示与前列腺癌相关的关键基因。
PLoS One. 2018 Aug 23;13(8):e0198055. doi: 10.1371/journal.pone.0198055. eCollection 2018.

引用本文的文献

1
Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients.前列腺癌患者预后基因特征的系统评价与综合分析
Discov Oncol. 2023 Dec 19;14(1):234. doi: 10.1007/s12672-023-00847-4.
2
An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer.一个与自噬相关的基因预后指数,可预测前列腺癌的生化复发、转移和耐药性。
Asian J Androl. 2023 Mar-Apr;25(2):208-216. doi: 10.4103/aja202281.
3
Plasticity of cancer invasion and energy metabolism.

本文引用的文献

1
MiRNA-Based Inspired Approach in Diagnosis of Prostate Cancer.基于 miRNA 的前列腺癌诊断方法研究。
Medicina (Kaunas). 2020 Feb 24;56(2):94. doi: 10.3390/medicina56020094.
2
Autophagy and autophagy-related proteins in cancer.癌症中的自噬和自噬相关蛋白。
Mol Cancer. 2020 Jan 22;19(1):12. doi: 10.1186/s12943-020-1138-4.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
癌症侵袭和能量代谢的可塑性。
Trends Cell Biol. 2023 May;33(5):388-402. doi: 10.1016/j.tcb.2022.09.009. Epub 2022 Oct 31.
4
microRNA-205 in prostate cancer: Overview to clinical translation.微小 RNA-205 在前列腺癌中的作用:从临床前研究到临床转化。
Biochim Biophys Acta Rev Cancer. 2022 Nov;1877(6):188809. doi: 10.1016/j.bbcan.2022.188809. Epub 2022 Oct 1.
5
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.靶向前列腺癌中的自噬:治疗反应的临床前和临床证据。
J Exp Clin Cancer Res. 2022 Mar 22;41(1):105. doi: 10.1186/s13046-022-02293-6.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer.前列腺癌中上皮-间充质转化相关 circRNA 和 miRNA 的筛选与鉴定。
Pathol Res Pract. 2020 Feb;216(2):152784. doi: 10.1016/j.prp.2019.152784. Epub 2019 Dec 19.
5
miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression.miRNA-29b 通过增加 Bim 表达抑制前列腺肿瘤生长并诱导细胞凋亡。
Cells. 2019 Nov 18;8(11):1455. doi: 10.3390/cells8111455.
6
MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.微小RNA作为前列腺癌的诊断、预后和治疗生物标志物
Crit Rev Eukaryot Gene Expr. 2019;29(2):127-139. doi: 10.1615/CritRevEukaryotGeneExpr.2019025273.
7
miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.miR-205-5p下调通过上调ERp29降低乳腺癌细胞对吉西他滨的敏感性。
Exp Ther Med. 2019 Nov;18(5):3525-3533. doi: 10.3892/etm.2019.7962. Epub 2019 Aug 30.
8
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.雄激素受体(AR)与基质金属蛋白酶 9/血管内皮生长因子(MMP9/VEGF)信号轴之间的功能联系是通过前列腺癌细胞中的 PIP5K1α/pAKT 介导的。
Int J Cancer. 2020 Mar 15;146(6):1686-1699. doi: 10.1002/ijc.32607. Epub 2019 Aug 16.
9
Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis.肿瘤突变负荷(TMB)与接受PD-1/PD-L1抑制剂治疗的癌症患者预后之间的关联:一项荟萃分析。
Front Pharmacol. 2019 Jun 14;10:673. doi: 10.3389/fphar.2019.00673. eCollection 2019.
10
Role of tumor and host autophagy in cancer metabolism.肿瘤和宿主自噬在癌症代谢中的作用。
Genes Dev. 2019 Jun 1;33(11-12):610-619. doi: 10.1101/gad.325514.119.